Seeking AlphaThu, 07 May 2026 13:11:14 GMTBiomea Fusion, Inc. (BMEA) Discusses Developments in Diabetes With Emphasis on Icovamenib and Clinical Trial Insights TranscriptBMEA+3.65%
Seeking AlphaTue, 28 Apr 2026 21:41:33 GMTBiomea Fusion, Inc. (BMEA) Discusses Top Line Results From COVALENT-112 Trial of Icovamenib in Type 1 Diabetes TranscriptBMEA+3.65%
Seeking AlphaTue, 31 Mar 2026 05:22:02 GMTBiomea Fusion, Inc. (BMEA) Discusses Menin Inhibition Mechanism and Therapeutic Potential in Diabetes TranscriptBMEA+3.65%
Seeking AlphaMon, 30 Mar 2026 19:22:23 GMTBiomea Fusion, Inc. (BMEA) Discusses Phase I Data and Clinical Potential of Oral GLP-1 Receptor Antagonist for Obesity TranscriptBMEA+3.65%